Sym023 (Anti-TIM-3) in Patients With Advanced Solid Tumor Malignancies or Lymphomas
Clinical trial NCT03489343 · COMPLETED
Trial details
- NCT number
- NCT03489343
- Sponsor
- Symphogen A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-24
- Primary completion
- 2020-06-03
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.